Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)
Tizanidine Tablet
Product Images NDC 50090-7889
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-7889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)
This text appears to be a comparison between taking 4 mg of Tizanidine capsules with food versus without food over a 24-hour period. It may be intended to show the effects or absorption rate of the medication based on whether it is taken with or without food. The numbers "2, 14, 16, 18" and "10" likely refer to the different time points during the 24 hours after taking the medication.*
Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)
Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)
This text discusses the improvement in Ashworth Score during a study, showing the mean dose used and the timeline at the end of titration (Study Week 3), end of maintenance (Study Week 7), and the endpoint with last observation carried forward.*
Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)
Label Image (Lbl500907889)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
